These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28657604)

  • 1. Fruit Fiber Consumption Specifically Improves Liver Health Status in Obese Subjects under Energy Restriction.
    Cantero I; Abete I; Monreal JI; Martinez JA; Zulet MA
    Nutrients; 2017 Jun; 9(7):. PubMed ID: 28657604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction.
    Krawczyk M; Maciejewska D; Ryterska K; Czerwińka-Rogowska M; Jamioł-Milc D; Skonieczna-Żydecka K; Milkiewicz P; Raszeja-Wyszomirska J; Stachowska E
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance, body composition, and fat distribution in obese children with nonalcoholic fatty liver disease.
    Yang HR; Chang EJ
    Asia Pac J Clin Nutr; 2016; 25(1):126-33. PubMed ID: 26965771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial.
    Marin-Alejandre BA; Abete I; Cantero I; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Quiroga J; Martinez-Echeverria A; Uriz-Otano JI; Huarte-Muniesa MP; Tur JA; Martinez JA; Zulet MA
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31652512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new dietary strategy for long-term treatment of the metabolic syndrome is compared with the American Heart Association (AHA) guidelines: the MEtabolic Syndrome REduction in NAvarra (RESMENA) project.
    de la Iglesia R; Lopez-Legarrea P; Abete I; Bondia-Pons I; Navas-Carretero S; Forga L; Martinez JA; Zulet MA
    Br J Nutr; 2014 Feb; 111(4):643-52. PubMed ID: 23968597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C--a randomized trial.
    Rusu E; Jinga M; Enache G; Rusu F; Dragomir AD; Ancuta I; Draguţ R; Parpala C; Nan R; Sima I; Ateia S; Stoica V; Cheţa DM; Radulian G
    Nutr J; 2013 Aug; 12():119. PubMed ID: 23941362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial.
    Katsagoni CN; Papatheodoridis GV; Ioannidou P; Deutsch M; Alexopoulou A; Papadopoulos N; Papageorgiou MV; Fragopoulou E; Kontogianni MD
    Br J Nutr; 2018 Jul; 120(2):164-175. PubMed ID: 29947322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of the RESMENA dietary pattern on oxidative stress in patients suffering from metabolic syndrome with hyperglycemia are associated to dietary TAC and fruit consumption.
    de la Iglesia R; Lopez-Legarrea P; Celada P; Sánchez-Muniz FJ; Martinez JA; Zulet MA
    Int J Mol Sci; 2013 Mar; 14(4):6903-19. PubMed ID: 23535332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay of atherogenic factors, protein intake and betatrophin levels in obese-metabolic syndrome patients treated with hypocaloric diets.
    Crujeiras AB; Zulet MA; Abete I; Amil M; Carreira MC; Martínez JA; Casanueva FF
    Int J Obes (Lond); 2016 Mar; 40(3):403-10. PubMed ID: 26443337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D deficiency in non-alcoholic fatty liver disease: The chicken or the egg?
    Lee SM; Jun DW; Cho YK; Jang KS
    Clin Nutr; 2017 Feb; 36(1):191-197. PubMed ID: 26615912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).
    Saokaew S; Kanchanasuwan S; Apisarnthanarak P; Charoensak A; Charatcharoenwitthaya P; Phisalprapa P; Chaiyakunapruk N
    Liver Int; 2017 Oct; 37(10):1535-1543. PubMed ID: 28294515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal changes in body weight and body composition among women previously treated for breast cancer consuming a high-vegetable, fruit and fiber, low-fat diet.
    Thomson CA; Rock CL; Giuliano AR; Newton TR; Cui H; Reid PM; Green TL; Alberts DS;
    Eur J Nutr; 2005 Feb; 44(1):18-25. PubMed ID: 15309460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease.
    Eslamparast T; Tandon P; Raman M
    Nutrients; 2017 Jul; 9(8):. PubMed ID: 28933748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of two personalized dietary strategies during a 2-year intervention in subjects with nonalcoholic fatty liver disease: A randomized trial.
    Marin-Alejandre BA; Cantero I; Perez-Diaz-Del-Campo N; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Quiroga J; Martinez-Echeverria A; Uriz-Otano JI; Huarte-Muniesa MP; Tur JA; Martinez JA; Abete I; Zulet MA
    Liver Int; 2021 Jul; 41(7):1532-1544. PubMed ID: 33550706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
    Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Hypocaloric Hyperproteic Diet on Gut Microbiota in Overweight or Obese Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study.
    Pataky Z; Genton L; Spahr L; Lazarevic V; Terraz S; Gaïa N; Rubbia-Brandt L; Golay A; Schrenzel J; Pichard C
    Dig Dis Sci; 2016 Sep; 61(9):2721-31. PubMed ID: 27142672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower fructose intake may help protect against development of nonalcoholic fatty liver in adolescents with obesity.
    OʼSullivan TA; Oddy WH; Bremner AP; Sherriff JL; Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Adams LA
    J Pediatr Gastroenterol Nutr; 2014 May; 58(5):624-31. PubMed ID: 24345826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.
    Dixon JB; Bhathal PS; O'Brien PE
    Obes Surg; 2006 Oct; 16(10):1278-86. PubMed ID: 17059735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients.
    Li C; Guo P; Okekunle AP; Ji X; Huang M; Qi J; Jiang Y; Feng R; Li R
    J Gastroenterol Hepatol; 2019 Jan; 34(1):256-262. PubMed ID: 29949199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.